Rapt Therapeutics, Inc. (RAPT)
58.02
0.00 (0.00%)
USD |
NASDAQ |
Mar 03, 16:00
Rapt Therapeutics Research and Development Expense (Annual) : 107.22M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Penumbra, Inc. | 69.43M |
| Amicus Therapeutics, Inc. | 135.84M |
| Disc Medicine, Inc. | 170.36M |
| Amylyx Pharmaceuticals, Inc. | 103.18M |
| Johnson & Johnson | 14.83B |